RisdiplamPneumonia following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36745-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：348 / 348

相关论文

共 50 条

[31] DimeticoneGranuloma following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 150 - 150
[32] CyproteroneMeningiomas following off-label use: case report
Reactions Weekly, 2021, 1849 (1) : 152 - 152
[33] RisperidonePancreatitis following off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 378 - 378
[34] CyclophosphamideMyelosuppression following off-label use: case report
Reactions Weekly, 2020, 1835 (1) : 116 - 116
[35] SirolimusNeutropenia following off-label use: case report
Reactions Weekly, 2023, 1960 (1) : 394 - 394
[36] DenosumabHypocalcaemia following off-label use: case report
Reactions Weekly, 2022, 1923 (1) : 178 - 178
[37] TemozolomideThrombocytopenia following off-label use: case report
Reactions Weekly, 2025, 2040 (1) : 934 - 934
[38] HydroxychloroquineEosinophilia following off-label use: case report
Reactions Weekly, 2021, 1867 (1) : 204 - 204
[39] DexamethasoneMucormycosis following off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 181 - 181
[40] GlibenclamideHypoglycaemia following an off-label use : case report
Reactions Weekly, 2021, 1866 (1) : 190 - 190

← 1 2 3 4 5 →